Angus Sidore

[Michael Fischbach @mfgrp]

How to pick a problem. Today in @CellCellPress. 1/53
https://t.co/Id4YaXWuup

[Calin Plesa @calinplesa]

Story time! Introducing the first of several new flavors of DropSynth #genesynthesis we have been working on, cooked up by @AlkynesOfSci and Sam Hinton. TLDR: We show multiple gene variants assembled per barcoded droplet and 1 kbp lengths. 1/n
https://t.co/8n8qiQA1ik

[Scribe Therapeutics @scribetx]

We’re proud to announce a strategic collaboration with Prevail Therapeutics, a subsidiary of @EliLillyandCo, that will leverage Scribe's #CRISPR X-Editing (XE) technologies to accelerate novel in vivo therapies for neurological and neuromuscular diseases. https://t.co/gHxrvTUgwq

[Sarah Denny @SarahSeq]

Excited to join this @SFBusinessTimes panel to share my career path from academia to industry. It’s an honor to represent @scribetx as one of #SFBTwomenwholead in the life sciences.

[Angus Sidore @angus_sidore]

@ChrisOmics Congrats Robles!

[Alex Cagan @ATJCagan]

Incredibly excited to share our paper ‘Somatic mutation rates scale with lifespan across mammals’ now published @nature.
https://t.co/a68IkkTt33
An illustrated & updated tweetorial… [1/24]

[Jordan Grimes (on Bluesky @cafedujord) @cafedujord]

A Berkeley homeowner who spends half his time at his second home in New Zealand used a California environmental law passed by Ronald Reagan to cut enrollment at one of the best universities in the world.

This sentence is unbelievable, yet somehow entirely factually accurate.

[David R. Liu @davidrliu]

Today we report in @CellCellPress an engineered virus-like particle (eVLP) platform that mediates efficient in vivo delivery of therapeutic proteins, including base editors and Cas9 nuclease, resulting in therapeutic editing in multiple mouse organs. 1/14
https://t.co/v1yBl296L6

[Patrick Hsu @pdhsu]

The ability of molecular biologists to control DNA has relied on enzymes derived from the phage-microbe arms race. In this new work, we systematically mined thousands of new serine integrases (LSRs) and developed them for human genome editing. 🧬

https://t.co/tjJKBvRPYc

[Calin Plesa @calinplesa]

Thrilled to announce that the @PlesaLab has received a New Innovator Award from @NIH_CommonFund to fund three crazy ideas mixed into one, with the ultimate goal of making antibodies.... lots of antibodies! #NIHHighRisk @UOKnightCampus 1/n

[Feng Zhang @zhangf]

CRISPR technologies are powerful gene editing tools because they are programmable. We are excited to describe 3 new programmable systems, IscB, IsrB, and TnpB, some of the most abundant genes on the planet, with potential for gene editing. @ScienceMagazine https://t.co/dY8FXBYIM8

[Ed Yong is not here @edyong209]

🚨I wrote a big piece about how Delta affects the pandemic endgame.

Many folks are upset & confused by the last month. Here's an attempt to reset expectations, lay out our goals, map the near-term future, & show how the pandemic ends--which it will. 1/

https://t.co/4Ukv7zs91X

[NPR @NPR]

The advance is being hailed not just for amyloidosis patients but also as a proof-of-concept that CRISPR could be used to treat many other, much more common diseases. https://t.co/mw8VN2cA8i

[Bloom Lab @jbloom_lab]

In a new study, I identify and recover a deleted set of #SARSCoV2 sequences that provide additional information about viruses from the early Wuhan outbreak: https://t.co/1zdeiOQ0vo (1/n)

[Romero lab @romerolab1]

Congrats to Hridindu for posting his DMS analysis of human executioner caspases https://t.co/LpX3VbrtS4

[Frank Sainsbury @FrankBioNano]

Yes!!! This is the COOLEST of the cool - evolution of virus-like features in capsid protein and packaging by a non-viral protein cage https://t.co/Z6xypGq8jG

[Mike Tisza @MikeTisza]

The pandemic has been bleak, but a great thing just happened. I'm excited to say that the manuscript I put together with my PhD mentor @ChrisB_Buck is now published in @PNASNews! Featuring tens of thousands of viruses from human metagenomes. (1/n)

https://t.co/Ui4sjl31CA

[Romero lab @romerolab1]

Excited to post Jonathan's paper using ML to engineer enzymes for fatty alcohol production https://t.co/ia9ekRmo0F

[Mark Charbonneau @charbo25]

The questions I get most often from PhD students are about what’s is like working in biotech. So, here are some of my observations on the industry that I wish I’d known in grad school (Note that everyone’s experience is different, so YMMV). #biotech #career (1/)